Viking Global Opportunities Illiquid Investments Sub-Master LP
Insider CIK 1629482 · ABUS 10% owner · ADPT 10% owner · PRCT 10% owner · ROIV 10% owner · AXON 10% owner · FDMT 10% owner · EDIT 10% owner · AMLX 10% owner · MYOV 10% owner · ZNTL 10% owner · RLYB 10% owner · INBX 10% owner · UROV 10% owner · BBIO 10% owner · APG 10% owner · RYZB 10% owner · FLAC 10% owner · DNA 10% owner · FIGS 10% owner · INBX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INBX Inhibrx Biosciences, Inc. | S Sale | 2025-10-07 | 2025-10-09 | 25,042 | $32.25 | $807.6K | 102,864 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2025-10-07 | 2025-10-09 | 308,643 | $32.25 | $9.95M | 1,267,823 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2025-10-07 | 2025-10-09 | 16,315 | $32.25 | $526.2K | 67,018 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 3,500,000 | $44.00 | $154.00M | 18,555,375 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-01-31 | 2025-01-31 | 3,065,616 | $34.90 | $106.99M | 22,055,375 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-06-17 | 2024-06-18 | 1,912,750 | $38.15 | $72.97M | 0 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-06-17 | 2024-06-18 | 39,032 | $38.15 | $1.49M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | J Other deriv | 2024-05-30 | 2024-06-03 | 1,038,765 | $30.00 | $31.16M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | J Other | 2024-05-30 | 2024-06-03 | 511,627 | $30.00 | $15.35M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | J Other | 2024-05-30 | 2024-06-03 | 333,333 | $30.00 | $10.00M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | J Other | 2024-05-30 | 2024-06-03 | 6,305,866 | $30.00 | $189.18M | 0 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-03-05 | 2024-03-07 | 2,977,845 | $34.25 | $101.99M | 1,912,750 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-03-05 | 2024-03-07 | 60,772 | $34.25 | $2.08M | 39,032 | SEC↗ |
| APG APi Group Corp | C Conversion deriv | 2024-02-28 | 2024-03-01 | 4,000 | — | $0 | 0 | SEC↗ |
| APG APi Group Corp | C Conversion deriv | 2024-02-28 | 2024-03-01 | 196,000 | — | $0 | 0 | SEC↗ |
| APG APi Group Corp | J Other | 2024-02-28 | 2024-03-01 | 81,300 | $36.90 | $3.00M | 99,804 | SEC↗ |
| APG APi Group Corp | J Other | 2024-02-28 | 2024-03-01 | 3,983,739 | $36.90 | $147.00M | 4,890,595 | SEC↗ |
| APG APi Group Corp | C Conversion | 2024-02-28 | 2024-03-01 | 164,016 | $24.60 | $4.03M | 181,104 | SEC↗ |
| APG APi Group Corp | C Conversion | 2024-02-28 | 2024-03-01 | 8,036,862 | $24.60 | $197.71M | 8,874,334 | SEC↗ |
| RYZB RayzeBio, Inc. | J Other | 2024-02-26 | 2024-02-28 | 1,743,556 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | J Other | 2024-02-26 | 2024-02-28 | 4,899,144 | — | $0 | 0 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-01-04 | 2024-01-05 | 540,000 | $19.53 | $10.55M | 4,247,914 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-01-02 | 2024-01-04 | 6,300,817 | $31.30 | $197.22M | 27,032,516 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-01-02 | 2024-01-04 | 195,200 | $31.30 | $6.11M | 837,472 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-01-02 | 2024-01-04 | 3,983 | $31.30 | $124.7K | 17,088 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 864,509 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 432,254 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 2,609,392 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 1,285,223 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 2,609,392 | — | $0 | 3,968,588 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 1,285,223 | — | $0 | 1,285,223 | SEC↗ |
| RYZB RayzeBio, Inc. | P Buy | 2023-09-19 | 2023-09-21 | 930,556 | $18.00 | $16.75M | 4,899,144 | SEC↗ |
| RYZB RayzeBio, Inc. | P Buy | 2023-09-19 | 2023-09-21 | 458,333 | $18.00 | $8.25M | 1,743,556 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 494,687 | — | $0 | 1,359,196 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 864,509 | — | $0 | 864,509 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-07-18 | 2023-07-19 | 1,500,000 | $35.00 | $52.50M | 25,120,991 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 5,427,043 | $9.90 | $53.73M | 31,409,512 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 5,236,006 | $9.90 | $51.84M | 30,303,871 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 2,226,195 | $9.90 | $22.04M | 12,884,307 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 110,756 | $9.90 | $1.10M | 641,010 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | P Buy | 2023-05-09 | 2023-05-11 | 850,000 | $16.00 | $13.60M | 4,787,914 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | C Conversion | 2022-11-22 | 2022-11-25 | 2,459,880 | — | $0 | 0 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | C Conversion | 2022-11-22 | 2022-11-25 | 1,211,582 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | P Buy deriv | 2022-11-15 | 2022-11-17 | 3,333,388 | $6.00 | $20.00M | 3,333,388 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-11-11 | 2022-01-13 | 4,870,536 | — | $0 | 0 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | P Buy | 2022-11-02 | 2022-11-04 | 279,530 | $10.08 | $2.82M | 1,211,582 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | P Buy | 2022-11-02 | 2022-11-04 | 567,532 | $10.08 | $5.72M | 2,459,880 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2022-10-07 | 2022-10-12 | 1,000,000 | $30.00 | $30.00M | 2,427,307 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2022-10-07 | 2022-10-12 | 333,333 | $30.00 | $10.00M | 333,333 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-09 | 2022-09-09 | 3,142 | $31.44 | $98.8K | 1,850,940 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-09 | 2022-09-09 | 73,886 | $30.90 | $2.28M | 1,854,082 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-09 | 2022-09-09 | 147,502 | $29.87 | $4.41M | 1,927,968 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-09 | 2022-09-09 | 6,654 | $31.44 | $209.2K | 3,919,596 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-09 | 2022-09-09 | 156,463 | $30.90 | $4.83M | 3,926,250 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-09 | 2022-09-09 | 312,353 | $29.87 | $9.33M | 4,082,713 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 108,631 | $28.16 | $3.06M | 4,681,190 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 80,715 | $27.28 | $2.20M | 4,789,821 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 159,026 | $29.14 | $4.63M | 4,522,164 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 52,466 | $32.23 | $1.69M | 2,075,470 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 7,554 | $30.59 | $231.1K | 2,127,936 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 75,096 | $29.14 | $2.19M | 2,135,490 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 51,298 | $28.16 | $1.44M | 2,210,586 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 38,116 | $27.28 | $1.04M | 2,261,884 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 111,102 | $32.23 | $3.58M | 4,395,066 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2022-09-08 | 2022-09-09 | 15,996 | $30.59 | $489.3K | 4,506,168 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | S Sale | 2022-03-18 | 2022-03-22 | 101,795 | $29.90 | $3.04M | 298,205 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | S Sale | 2022-03-18 | 2022-03-22 | 1,147,205 | $29.90 | $34.30M | 3,360,687 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | J Other deriv | 2022-03-02 | 2022-03-04 | 288,000,000 | — | $0 | 288,000,000 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | J Other | 2022-03-02 | 2022-03-04 | 288,000,000 | — | $0 | 51,055,144 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-11 | 2022-01-13 | 4,870,536 | — | $0 | 4,870,536 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | P Buy | 2022-01-11 | 2022-01-13 | 2,300,000 | $19.00 | $43.70M | 2,300,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 3,407,028 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 113,737 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion deriv | 2021-09-17 | 2021-09-21 | 678,985 | — | $0 | 0 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion | 2021-09-17 | 2021-09-21 | 678,985 | — | $0 | 4,394,155 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion | 2021-09-17 | 2021-09-21 | 113,737 | — | $0 | 4,507,892 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | P Buy | 2021-09-17 | 2021-09-21 | 400,000 | $35.00 | $14.00M | 400,000 | SEC↗ |
| PRCT PROCEPT BioRobotics Corp | C Conversion | 2021-09-17 | 2021-09-21 | 3,407,028 | — | $0 | 3,715,170 | SEC↗ |
| FIGS FIGS, Inc. | S Sale | 2021-09-03 | 2021-09-03 | 42,413 | $44.92 | $1.91M | 14,742,689 | SEC↗ |
| FIGS FIGS, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 157,587 | $47.28 | $7.45M | 14,785,102 | SEC↗ |
| RLYB Rallybio Corp | C Conversion deriv | 2021-07-29 | 2021-08-02 | 21,578,387 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-07-29 | 2021-08-02 | 806,000 | $13.00 | $10.48M | 4,194,777 | SEC↗ |
| RLYB Rallybio Corp | C Conversion | 2021-07-29 | 2021-08-02 | 3,388,777 | — | $0 | 3,388,777 | SEC↗ |
| FDMT 4D Molecular Therapeutics | C Conversion deriv | 2020-12-15 | 2020-12-17 | 2,004,581 | — | $0 | 0 | SEC↗ |
| FDMT 4D Molecular Therapeutics | C Conversion deriv | 2020-12-15 | 2020-12-17 | 833,333 | — | $0 | 0 | SEC↗ |
| FDMT 4D Molecular Therapeutics | C Conversion | 2020-12-15 | 2020-12-17 | 833,333 | — | $0 | 2,837,914 | SEC↗ |
| FDMT 4D Molecular Therapeutics | P Buy | 2020-12-15 | 2020-12-17 | 1,100,000 | $23.00 | $25.30M | 3,937,914 | SEC↗ |
| FDMT 4D Molecular Therapeutics | C Conversion | 2020-12-15 | 2020-12-17 | 2,004,581 | — | $0 | 2,004,581 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-01 | 2020-12-03 | 500,000 | $50.50 | $25.25M | 3,943,284 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-11-11 | 2020-11-13 | 2,500,000 | $49.52 | $123.80M | 30,993,708 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2020-08-26 | 2020-08-28 | 100,000 | $18.99 | $1.90M | 1,427,307 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2020-08-26 | 2020-08-28 | 80,219 | $18.84 | $1.51M | 1,327,307 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2020-08-25 | 2020-08-25 | 14,825 | $19.23 | $285.1K | 1,176,609 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2020-08-25 | 2020-08-25 | 70,479 | $19.39 | $1.37M | 1,247,088 | SEC↗ |
| INBX Inhibrx, Inc. | P Buy | 2020-08-24 | 2020-08-25 | 46,161 | $19.43 | $896.9K | 1,161,784 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2020-04-07 | 2020-04-08 | 725,000 | $18.00 | $13.05M | 4,443,284 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-01-28 | 2020-01-30 | 4,912,899 | $24.98 | $122.72M | 33,493,708 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 2,007,740 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 18,908,945 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 290,572 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 15,524,350 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 290,572 | — | $0 | 38,406,607 | SEC↗ |
| ADPT Adaptive Biotechnologies C | P Buy | 2019-07-01 | 2019-07-02 | 250,000 | $20.00 | $5.00M | 1,675,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 18,908,945 | — | $0 | 20,583,945 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 15,524,350 | — | $0 | 36,108,295 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 2,007,740 | — | $0 | 38,116,035 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion deriv | 2019-06-27 | 2019-06-28 | 50,446,451 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion deriv | 2019-06-27 | 2019-06-28 | 51,781,276 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion | 2019-06-27 | 2019-06-28 | 11,736,137 | — | $0 | 11,736,137 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2019-06-27 | 2019-06-28 | 4,705,900 | $17.00 | $80.00M | 26,620,991 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion | 2019-06-27 | 2019-06-28 | 10,178,954 | — | $0 | 21,915,091 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-13 | 2,424,242 | $8.25 | $20.00M | 40,765,599 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $9995.00 | $99.90M | 22,735,272 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2019-03-18 | 2019-03-19 | 6,666,667 | $1.50 | $10.00M | 105,952,381 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-12-18 | 2018-12-20 | 10,000,000 | $1.00 | $10.00M | 99,285,714 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2018-10-01 | 2018-10-03 | 2,678,571 | $14.00 | $37.50M | 22,703,669 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-06-05 | 2018-06-07 | 14,285,714 | $1.75 | $25.00M | 89,285,714 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2018-04-02 | 2018-04-05 | 1,110,015 | $20.27 | $22.50M | 38,341,357 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2018-01-12 | 2018-01-16 | 664,000 | $100.00 | $66.40M | 1,164,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2017-10-16 | 2017-10-17 | 500,000 | $100.00 | $50.00M | 500,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 481,567 | — | $0 | 481,567 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 256,986 | — | $0 | 256,986 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 15,072 | — | $0 | 15,072 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-08 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 261,447 | — | $0 | 261,447 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 5,335 | — | $0 | 266,782 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-08 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 1,000,000 | — | $0 | 2,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 20,407 | — | $0 | 2,729,808 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 256,986 | — | $0 | 256,986 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-09 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 261,447 | — | $0 | 261,447 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 481,567 | — | $0 | 481,567 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 15,072 | — | $0 | 15,072 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 5,335 | — | $0 | 266,782 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-09 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 20,407 | — | $0 | 2,729,808 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 1,000,000 | — | $0 | 2,709,401 | SEC↗ |